Floatz logo

CIS-DIAMMINEDICHLOROPLATINUM II

Advanced Pancreatic, Colon, Lung, Gastric and Ovarian Cancer

National Cancer Institute (NCI)Small moleculePhase 2Active
BB
67/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Advanced Pancreatic, Colon, Lung, Gastric and Ovarian Cancer cohort.

Asset / SponsorPhaseRating
Enoxaparin
Beth Israel Deaconess Medical Center
Phase 2B

Same molecule, other indications

CIS-DIAMMINEDICHLOROPLATINUM II is also rated in:

squamous cell lung carcinomaDormant
BBB
Indicative ·
78 / 100
View asset →
primary peritoneal carcinomaDormant
BBB
Indicative ·
77 / 100
View asset →
adenocarcinomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →